Adaptive Clinical Trials as Topic MeSH Descriptor Data 2023

MeSH Heading: Adaptive Clinical Trials as Topic
Tree Number(s): E05.318.372.250.250.100; N05.715.360.330.250.250.100; N06.850.520.450.250.250.100
Unique ID: D000075522
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000075522
Annotation: for general design, methodology, economics, etc. of adaptive clinical trials; a different heading ADAPTIVE CLINICAL TRIAL is used for reports of a specific adaptive clinical trial
Scope Note: Works about clinical studies in which a prospectively planned opportunity is included to modify trial designs and hypotheses based on analysis of data from subjects in the study.
Entry Term(s): Adaptive Clinical Trial Design; Adaptive Clinical Trial as Topic
Public MeSH Note: 2018
History Note: 2018
Date Established: 2018/01/01
Date of Entry: 2017/07/11
Revision Date: 2018/06/29

Allowable Qualifiers: adverse effects (AE)

classification (CL)

economics (EC)

ethics (ES)

history (HI)

instrumentation (IS)

legislation & jurisprudence (LJ)

methods (MT)

organization & administration (OG)

psychology (PX)

standards (ST)

statistics & numerical data (SN)

trends (TD)

veterinary (VE)

Investigative Techniques [E05]
- Epidemiologic Methods [E05.318]
  - Epidemiologic Study Characteristics [E05.318.372]
    - Clinical Studies as Topic [E05.318.372.250]
      - Clinical Trials as Topic [E05.318.372.250.250]
        
        Adaptive Clinical Trials as Topic [E05.318.372.250.250.100]
        
        Clinical Trials, Phase I as Topic [E05.318.372.250.250.200]
        
        Clinical Trials, Phase II as Topic [E05.318.372.250.250.210]
        
        Clinical Trials, Phase III as Topic [E05.318.372.250.250.220]
        
        Clinical Trials, Phase IV as Topic [E05.318.372.250.250.230]
        
        Controlled Clinical Trials as Topic [E05.318.372.250.250.365]
        
        Single-Case Studies as Topic [E05.318.372.250.250.682]

Health Care Quality, Access, and Evaluation [N05]
- Quality of Health Care [N05.715]
  - Health Care Evaluation Mechanisms [N05.715.360]
    - Epidemiologic Study Characteristics [N05.715.360.330]
      - Clinical Studies as Topic [N05.715.360.330.250]
        
        Clinical Trials as Topic [N05.715.360.330.250.250]
        
        Adaptive Clinical Trials as Topic [N05.715.360.330.250.250.100]
        
        Clinical Trials, Phase I as Topic [N05.715.360.330.250.250.200]
        
        Clinical Trials, Phase II as Topic [N05.715.360.330.250.250.210]
        
        Clinical Trials, Phase III as Topic [N05.715.360.330.250.250.220]
        
        Clinical Trials, Phase IV as Topic [N05.715.360.330.250.250.230]
        
        Controlled Clinical Trials as Topic [N05.715.360.330.250.250.365]
        
        Single-Case Studies as Topic [N05.715.360.330.250.250.682]

Environment and Public Health [N06]
- Public Health [N06.850]
  - Epidemiologic Methods [N06.850.520]
    - Epidemiologic Study Characteristics [N06.850.520.450]
      - Clinical Studies as Topic [N06.850.520.450.250]
        
        Clinical Trials as Topic [N06.850.520.450.250.250]
        
        Adaptive Clinical Trials as Topic [N06.850.520.450.250.250.100]
        
        Clinical Trials, Phase I as Topic [N06.850.520.450.250.250.200]
        
        Clinical Trials, Phase II as Topic [N06.850.520.450.250.250.210]
        
        Clinical Trials, Phase III as Topic [N06.850.520.450.250.250.220]
        
        Clinical Trials, Phase IV as Topic [N06.850.520.450.250.250.230]
        
        Controlled Clinical Trials as Topic [N06.850.520.450.250.250.365]
        
        Single-Case Studies as Topic [N06.850.520.450.250.250.682]

Adaptive Clinical Trials as Topic Preferred

page delivered in 0.153s